Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchneuropathic painpreclinicalpeptide therapeutics

Fierce Biotech reports peptide acting as decoy for neuropathic pain in mice

The biotech's candidate is described as a bait molecule, with the reported results limited to a mouse model of neuropathic pain.

PR
By Priya Raman · Science Reporter
Oct 6 11:00 ETSource: Fierce Biotech

The wire

  1. 01Fierce Biotech reports a biotech's peptide showed activity as a bait molecule against neuropathic pain in mice.
  2. 02Neuropathic pain remains poorly served by existing drugs, so clinicians and investors track early peptide approaches in the space.
  3. 03Findings are preclinical and in rodents; dose, mechanism detail and any path to human testing remain to be established.

From the source

Biotech’s peptide shows promise as ‘bait molecule’ to treat neuropathic pain in mice

Read at fiercebiotech.com
PeptiPrescribed peptides from $99/moSee all →